ahlam1399
06-30-2015, 12:50 AM
Celegene, Ju** collaborate to develop cancer therapies
June 29 (Reuters) - Celgene Corp and Ju** Therapeutics Inc said they signed a deal to develop and commercialize immu**therapies for the treatment of cancer and autoimmune diseases.
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2.img (http://da.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/ach.img (http://adchoice.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/ach.htm)http://pi.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2t.imghttp://pi2.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47ae0c89/sc/32/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_IYkhqKLcGo:hxLK4xhc590:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_IYkhqKLcGo:hxLK4xhc590:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_IYkhqKLcGo
June 29 (Reuters) - Celgene Corp and Ju** Therapeutics Inc said they signed a deal to develop and commercialize immu**therapies for the treatment of cancer and autoimmune diseases.
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2.img (http://da.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/ach.img (http://adchoice.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/ach.htm)http://pi.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2t.imghttp://pi2.feedsportal.com/r/233193928993/u/49/f/654213/c/35217/s/47ae0c89/sc/32/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47ae0c89/sc/32/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_IYkhqKLcGo:hxLK4xhc590:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_IYkhqKLcGo:hxLK4xhc590:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_IYkhqKLcGo:hxLK4xhc590:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_IYkhqKLcGo